Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers

Overview of attention for article published in Frontiers in Pharmacology, January 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 8,609 followers.

Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers https://t.co/gaRMXO6xCk

New article: Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers https://t.co/MrBSYnwUMW #livercancer #oncology https://t.co/6tXbc3sDu0

New article: Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers https://t.co/Q7LD5MFuuH #colorectalcancer #oncology https://t.co/delMtx9AJ8

RT @FrontPharmacol: New Research: Current Advances in Coptidis Rhizoma for Gastrointestinal and Other Cancers https://t.co/oPMDsSrUUF #phar…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.